← Leaderboards
Louis N. Martin
Tulane University Of Louisiana
$599,825
Attributed
$599,825
Total exposure
11
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $201.2K · FY2005–06$250K$187.5K$125K$62.5K$0
'05
'06
Funding mix
By agency
NIH$599,825 · 11
By mechanism
P51$599,825 · 11
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Rudolf P Bohm$51,450,972
- Ronald S. Veazey$44,796,137
- Russell Barrett Van Dyke$24,377,705
- James L Blanchard$16,717,439
- Juan J. L. Lertora$4,837,795
Others in their field
Top investigators on “Aids”
- Judith S. Currier · University Of California Los Angeles$495,238,846
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$400,385,565
- Lawrence Corey · Fred Hutchinson Cancer Center$397,189,786
- David Heimbrook · Leidos Biomedical Research, Inc.$340,483,893
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$316,384,846
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$310,253,675
Research focus
AidsCommunicable DiseasesImmunologyInflammationLymphatic SystemVirusMammaliaSexually Transmitted DiseasesAnimal TissueHematologyPharmacologyModel Design /DevelopmentDrug Adverse EffectParasitismStatistics /BiometryIntestinesLiverTechnology /Technique DevelopmentMaleImmunologic Assay /TestMicroscopyHuman TissueParasite Infection MechanismEpidemiology
Grant awards (17)
DEVELOPMENT OF EFFECTIVE HIV VACCINE$65,435
P51 · FY2006 · RR · contact PI
EVALUATION OF A MULTI-ENVELOPE HIV VACCINE$54,500
P51 · FY2005 · RR
DEVELOPMENT OF CORE SERVICE FOR SIV CELLULAR IMMUNE ASSAYS$54,500
P51 · FY2005 · RR
COINCIDENT AIDS/RELAPSING MALARIA$54,500
P51 · FY2005 · RR
CORE SERVICE FOR FLOW CYTOMETRY$37,662
P51 · FY2005 · RR
DEVELOPMENT OF CORE SERVICE: SIV CELLULAR IMMUNE ASSAYS$47,161
P51 · FY2004 · RR
DEVELOPMENT OF CORE SERVICE FOR SIV CELLULAR IMMUNE ASSAYS$61,544
P51 · FY2003 · RR
EFFECTS OF CARRAGEENAN ON VAGINAL TRANSMISSION OF SIV IN RHESUS MONKEYS$61,544
P51 · FY2003 · RR
COINFECTION W/ SIV &MALARIA$0
P51 · FY2002 · RR
AIDS THERAPIES IN ANIMAL RETROVIRUS MODELS: SIV$0
P51 · FY2002 · RR
INFECTION OF MONKEYS BY INTRAVAGINAL INOCULATION OF SIV: HORMONAL EFFECTS$0
P51 · FY2002 · RR
COINFECTION W/ SIV &MALARIA$0
P51 · FY2001 · RR
INFECTION OF MONKEYS BY INTRAVAGINAL INOCULATION OF SIV: HORMONAL EFFECTS$0
P51 · FY2001 · RR
AIDS THERAPIES IN ANIMAL RETROVIRUS MODELS: SIV$0
P51 · FY2001 · RR
EFFECTS OF THYMECTOMY ON COURSE OF SIV INFECTION$54,327
P51 · FY2000 · RR
DOSE RESPONSE TO PMPA TREATMENT POSTINOCULATION IN SIV INFECTED RHESUS MONKEYS$54,327
P51 · FY2000 · RR
NON OXYNOL 9 ON VAGINAL INFECTION W/ SIV IN PROGESTERONE TREATED RHESUS MONKEYS$54,325
P51 · FY2000 · RR